Fulzos 250mg Injection
Marketer
Hetero Healthcare Limited
Salt Composition
Fulvestrant (250mg)
Overview Fulzos 250mg Injection
Estrogen-blocking medication, Fulzos 250mg Injection, is indicated for postmenopausal women with breast cancer. Its mechanism involves estrogen level modulation to inhibit cancer cell proliferation. Administered intramuscularly by a healthcare professional, dosage and frequency are determined by the treating physician based on individual needs and treatment goals. The prescribed duration should be adhered to. Common adverse effects encompass injection site reactions, headache, nausea, vomiting, and allergic responses. Report any concerning symptoms to your physician; management strategies may be available. Prior to commencing treatment, inform your doctor of any pre-existing conditions, including liver or kidney impairment, bleeding disorders, or anticoagulant use. Complete disclosure of all concurrent medications is crucial, as interactions may compromise efficacy or alter the drug's action. Disclose pregnancy, pregnancy plans, or breastfeeding to your physician.
Uses of Fulzos 250mg Injection
Malignant breast tumor
Major Benefits of Fulzos 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Fulzos 250mg Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use Fulzos 250mg Injection:
This medication will be administered by your physician or their designated nursing staff; self-medication is strictly prohibited.
How Fulzos 250mg Injection works:
Fulzos 250mg Injection inhibits estrogen's effects on breast cancer cells, potentially suppressing or halting the proliferation of estrogen-dependent tumors.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Fulzos 250mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Fulzos 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Fulzos 250mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates the drug may harm the nursing infant.
DrivingSAFE
Driving ability is typically unaffected by Fulzos 250mg Injection.
KidneyCAUTION
Administering Fulzos 250mg Injection to individuals with severe kidney impairment requires careful consideration. A modified dosage of Fulzos 250mg Injection might be necessary. Physician consultation is advised. Data regarding Fulzos 250mg Injection use in such patients is limited. Dosage alteration is not suggested for those with mild or moderate kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Fulzos 250mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Fulzos 250mg Injection :
Omit a Fulzos 250mg Injection dose? Seek your physician's advice.
Facts to Know About Fulzos 250mg Injection
Label | Value |
---|---|
Chemical Type | Estrogen Derivatives |
Developing Habits | No. |
Treatment Category | Cancer Treatments |
Action Class | Estrogen receptor blocker |